scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1024854717 |
P356 | DOI | 10.1007/S002800051007 |
P698 | PubMed publication ID | 10803922 |
P2093 | author name string | Chiu CF | |
Hsueh CT | |||
Kelsen DP | |||
Schwartz GK | |||
P433 | issue | 5 | |
P304 | page(s) | 389-396 | |
P577 | publication date | 2000-01-01 | |
P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
P1476 | title | Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis | |
P478 | volume | 45 |
Q44413732 | A low toxicity maintenance regime, using eicosapentaenoic acid and readily available drugs, for mantle cell lymphoma and other malignancies with excess cyclin D1 levels |
Q38572743 | Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib |
Q31156666 | Apoptosis of human gastric cancer SGC-7901 cells induced by mitomycin combined with sulindac |
Q44163463 | Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survival |
Q35543115 | COX-2 inhibitors in oncology |
Q35426181 | Celecoxib and acetylbritannilactone interact synergistically to suppress breast cancer cell growth via COX-2-dependent and -independent mechanisms |
Q36179801 | Cyclooxygenase-2 expression and angiogenesis in colorectal cancer |
Q42712050 | Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cell death |
Q41790787 | Effects of Chinese herbal medicine in combination with mitomycin C on gastric cancer cells |
Q36178297 | Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma |
Q34605197 | Expression of cyclooxygenase-2 in colorectal cancer and its clinical significance |
Q33183406 | Growth inhibition and apoptosis induction of Sulindac on Human gastric cancer cells. |
Q36622317 | Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells. |
Q35557450 | Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents? |
Q36989141 | Metronomic chemotherapy and radiotherapy as salvage treatment in refractory or relapsed pediatric solid tumours |
Q38006448 | Metronomic chemotherapy in progressive pediatric malignancies: old drugs in new package |
Q34569946 | Metronomic scheduling: the future of chemotherapy? |
Q43799887 | Resveratrol-induced inactivation of human gastric adenocarcinoma cells through a protein kinase C-mediated mechanism |
Q35806751 | Role of COX-2 inhibitors in cancer therapy |
Q55260793 | The role of bile acids in cellular invasiveness of gastric cancer. |
Q36439206 | Two COX-2 inhibitors induce apoptosis in human erythroleukemia K562cells by modulating NF-κB and FHC pathways |
Search more.